BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10635383)

  • 21. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck.
    Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
    Virchows Arch; 2002 Aug; 441(2):133-42. PubMed ID: 12189502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of molecular markers and gene profiling in head and neck cancers.
    Gold KA; Kim ES
    Curr Opin Oncol; 2009 May; 21(3):206-11. PubMed ID: 19346943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene profiling in squamous cell carcinoma of the head and neck.
    Akervall J
    Cancer Metastasis Rev; 2005 Jan; 24(1):87-94. PubMed ID: 15785874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of expression of ZAC/LOT1 in squamous cell carcinomas of head and neck.
    Koy S; Hauses M; Appelt H; Friedrich K; Schackert HK; Eckelt U
    Head Neck; 2004 Apr; 26(4):338-44. PubMed ID: 15054737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Image cytometry of cyclin D1: a prognostic marker for head and neck squamous cell carcinomas.
    Liu SC; Zhang SY; Babb JS; Ridge JA; Klein-Szanto AJ
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):455-9. PubMed ID: 11352854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Head and neck squamous cell carcinoma cell lines as a model system for the study of oncogene expression during tumor progression and metastasis.
    Gallick GE; Sacks PG; Maxwell SA; Steck PA; Gutterman JU
    Prog Clin Biol Res; 1986; 212():97-111. PubMed ID: 3012576
    [No Abstract]   [Full Text] [Related]  

  • 27. Differential gene expression signature between primary and metastatic head and neck squamous cell carcinoma.
    Liu CJ; Liu TY; Kuo LT; Cheng HW; Chu TH; Chang KW; Lin SC
    J Pathol; 2008 Mar; 214(4):489-97. PubMed ID: 18213732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene expression profiling of head and neck squamous cell carcinoma using cDNA microarrays.
    Gottschlich S; Ambrosch P; Cordes C; Görögh T; Schreiber S; Häsler R
    Int J Oncol; 2006 Sep; 29(3):605-13. PubMed ID: 16865276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Skp2, p27kip1 and EGFR assessment in head and neck squamous cell carcinoma: prognostic implications.
    Carracedo DG; Astudillo A; Rodrigo JP; Suarez C; Gonzalez MV
    Oncol Rep; 2008 Sep; 20(3):589-95. PubMed ID: 18695910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns of gene promoter methylation in squamous cell cancer of the head and neck.
    Hasegawa M; Nelson HH; Peters E; Ringstrom E; Posner M; Kelsey KT
    Oncogene; 2002 Jun; 21(27):4231-6. PubMed ID: 12082610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular markers as prognostic factors for local recurrence and radioresistance in head and neck squamous cell carcinoma.
    Smith BD; Haffty BG
    Radiat Oncol Investig; 1999; 7(3):125-44. PubMed ID: 10406054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular markers of metastasis in squamous carcinomas.
    Helliwell TR
    J Pathol; 2001 Jul; 194(3):289-93. PubMed ID: 11439359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma.
    Kim MJ; Lim KY; Kim JW; Nam IW; Lee JH; Myoung H
    Cancer Lett; 2005 Jun; 224(2):253-61. PubMed ID: 15914276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Status of primary tumour surgical margins in squamous head and neck cancer: prognostic implications.
    Bradley PJ; MacLennan K; Brakenhoff RH; Leemans CR
    Curr Opin Otolaryngol Head Neck Surg; 2007 Apr; 15(2):74-81. PubMed ID: 17413406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomarkers of squamous cell carcinoma of the head and neck.
    Kim J; Shin DM
    Histol Histopathol; 1997 Jan; 12(1):205-18. PubMed ID: 9046056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allelic loss and tumor pathology in head and neck squamous cell carcinoma.
    Rybicki BA; Savera AT; Gomez JA; Patel SC; Ballard NE; Benninger MS; Zarbo RJ; Van Dyke DL
    Mod Pathol; 2003 Oct; 16(10):970-9. PubMed ID: 14559979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells.
    Sun SY; Yue P; Mao L; Dawson MI; Shroot B; Lamph WW; Heyman RA; Chandraratna RA; Shudo K; Hong WK; Lotan R
    Clin Cancer Res; 2000 Apr; 6(4):1563-73. PubMed ID: 10778990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The presence of multiple regions of homozygous deletion at the CSMD1 locus in oral squamous cell carcinoma question the role of CSMD1 in head and neck carcinogenesis.
    Toomes C; Jackson A; Maguire K; Wood J; Gollin S; Ishwad C; Paterson I; Prime S; Parkinson K; Bell S; Woods G; Markham A; Oliver R; Woodward R; Sloan P; Dixon M; Read A; Thakker N
    Genes Chromosomes Cancer; 2003 Jun; 37(2):132-40. PubMed ID: 12696061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.
    Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST
    J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma.
    Masuda M; Suzui M; Yasumatu R; Nakashima T; Kuratomi Y; Azuma K; Tomita K; Komiyama S; Weinstein IB
    Cancer Res; 2002 Jun; 62(12):3351-5. PubMed ID: 12067972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.